Intra-Cellular Therapies Inc (ITCI)
73.30
+0.09
(+0.12%)
USD |
NASDAQ |
Sep 27, 16:00
73.33
+0.03
(+0.04%)
After-Hours: 20:00
Intra-Cellular Therapies Operating Income (Quarterly)
Operating Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Operating Income (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -- |
March 31, 2024 | -- |
December 31, 2023 | -- |
September 30, 2023 | -- |
June 30, 2023 | -- |
March 31, 2023 | -- |
December 31, 2022 | -- |
September 30, 2022 | -- |
June 30, 2022 | -- |
March 31, 2022 | -- |
December 31, 2021 | -- |
September 30, 2021 | -- |
June 30, 2021 | -- |
March 31, 2021 | -- |
December 31, 2020 | -- |
September 30, 2020 | -- |
June 30, 2020 | -- |
March 31, 2020 | -- |
December 31, 2019 | -- |
September 30, 2019 | -- |
June 30, 2019 | -- |
March 31, 2019 | -- |
December 31, 2018 | -- |
Date | Value |
---|---|
September 30, 2018 | -- |
June 30, 2018 | -- |
March 31, 2018 | -- |
December 31, 2017 | -- |
September 30, 2017 | -- |
June 30, 2017 | -- |
March 31, 2017 | -- |
December 31, 2016 | -- |
September 30, 2016 | -- |
June 30, 2016 | -- |
March 31, 2016 | -- |
December 31, 2015 | -- |
September 30, 2015 | -- |
June 30, 2015 | -- |
March 31, 2015 | -- |
December 31, 2014 | -- |
September 30, 2014 | -- |
June 30, 2014 | -- |
March 31, 2014 | -- |
December 31, 2013 | -- |
September 30, 2013 | -- |
June 30, 2013 | -- |
Operating Income Definition
Profit earned from a company's core business operations. It is gross profit less all operating expenses and depreciation.